Quest Diagnostics Inc
NYSE:DGX
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.8B USD | 14.4 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
90.3B EUR | 10.4 | |
US |
Cigna Corp
NYSE:CI
|
96.3B USD | 10.2 | ||
US |
CVS Health Corp
NYSE:CVS
|
72.1B USD | 11 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
18.1B USD | 17.9 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 6.2 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12.2B EUR | 8.2 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
12.2B EUR | 8.2 | ||
US |
DaVita Inc
NYSE:DVA
|
12B USD | 14.1 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -32.4 | ||
AU |
Sonic Healthcare Ltd
ASX:SHL
|
12.9B AUD | 13.6 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.